Transurethral Fulguration Alleviates Pelvic Pain in Interstitial Cystitis
By Elana Gotkine HealthDay Reporter
MONDAY, May 5, 2025 -- For patients with interstitial cystitis (IC), transurethral fulguration (TUF) is effective for alleviating pelvic pain, according to a study published online April 3 in Neurourology and Urodynamics.
Hyun Ju Jeong, from the Seoul National University College of Medicine in South Korea, and colleagues conducted a retrospective analysis of electronic medical records of patients with IC who visited outpatient clinics with pelvic pain. Cystoscopic surgery based on TUF for bladder ulcers was used to manage pain; intractable pelvic pain was treated with cystectomy.
Overall, 240 of 275 patients underwent initial cystoscopic surgery; the mean number of TUF procedures was 1.0 during a median follow-up of 21.0 months. The researchers found that 71 of the 240 patients (29.6 percent) did not require further surgical treatment, while 26.7 percent required a second TUF for recurrent pelvic pain, with a median recurrence interval of 12.0 months. Fifteen of the 64 patients who received a second TUF (23.4 percent) underwent a third TUF after a median of 12.0 months. Five of the 15 patients who received a third TUF underwent a fourth TUF due to pain recurrence. One patient received a seventh TUF. Pain control with TUF was achieved by 168 of the 240 patients (70.0 percent). Eighteen (7.5 percent) of the patients underwent cystectomy.
"Our study results showed that TUFâbased cystoscopic surgery is an effective basic treatment for pelvic pain management in patients with IC," the authors write.
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
© 2025 HealthDay. All rights reserved.
Posted May 2025
Read this next
Presurgical Immunotherapy Offers Long-Term Benefit in Melanoma
FRIDAY, July 18, 2025 -- Neoadjuvant systemic treatment (NST) followed by adjuvant treatment with nivolumab and relatlimab offers long-term benefit in adults with stage III/IV...
Velar Adhesion Reduces Cleft Width Prior to Palatoplasty in Cleft Lip
TUESDAY, July 15, 2025 -- For patients with unilateral cleft lip and palate (UCLP), velar adhesion (VA) reduces cleft width prior to palatoplasty and is associated with a lower...
Wearable-Derived Biorhythms Predict Complications After Appendectomy
MONDAY, July 14, 2025 -- Wearable-derived biorhythms can predict postoperative complications in children undergoing appendectomy, according to a study published online July 9 in...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.